KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Biomarin Pharmaceutical (BMRN) Shares Outstanding: 2009-2022

Historic Shares Outstanding for Biomarin Pharmaceutical (BMRN) over the last 6 years, with Jun 2022 value amounting to $185.5 million.

  • Biomarin Pharmaceutical's Shares Outstanding rose 1.16% to $185.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $185.5 million, marking a year-over-year increase of 1.16%. This contributed to the annual value of $183.9 million for FY2021, which is 1.20% up from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Shares Outstanding of $185.5 million as of Q2 2022, which was up 0.30% from $184.9 million recorded in Q1 2022.
  • In the past 5 years, Biomarin Pharmaceutical's Shares Outstanding ranged from a high of $185.5 million in Q2 2022 and a low of $176.7 million during Q1 2018.
  • Over the past 3 years, Biomarin Pharmaceutical's median Shares Outstanding value was $183.0 million (recorded in 2021), while the average stood at $182.9 million.
  • Data for Biomarin Pharmaceutical's Shares Outstanding shows a peak YoY increased of 1.93% (in 2018) over the last 5 years.
  • Biomarin Pharmaceutical's Shares Outstanding (Quarterly) stood at $178.3 million in 2018, then climbed by 0.89% to $179.8 million in 2019, then climbed by 1.06% to $181.7 million in 2020, then rose by 1.20% to $183.9 million in 2021, then grew by 1.16% to $185.5 million in 2022.
  • Its Shares Outstanding stands at $185.5 million for Q2 2022, versus $184.9 million for Q1 2022 and $183.9 million for Q4 2021.